BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26896490)

  • 1. Coverage analysis in a targeted amplicon-based next-generation sequencing panel for myeloid neoplasms.
    Yan B; Hu Y; Ng C; Ban KH; Tan TW; Huan PT; Lee PL; Chiu L; Seah E; Ng CH; Koay ES; Chng WJ
    J Clin Pathol; 2016 Sep; 69(9):801-4. PubMed ID: 26896490
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Ng CWS; Kosmo B; Lee PL; Lee CK; Guo J; Chen Z; Chiu L; Lee HK; Ho S; Zhou J; Lin M; Tan KML; Ban KHK; Tan TW; Chng WJ; Yan B
    J Clin Pathol; 2018 Jun; 71(6):522-531. PubMed ID: 29180507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms.
    Au CH; Wa A; Ho DN; Chan TL; Ma ES
    Diagn Pathol; 2016 Jan; 11():11. PubMed ID: 26796102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategy for robust detection of insertions, deletions, and point mutations in CEBPA, a GC-rich content gene, using 454 next-generation deep-sequencing technology.
    Grossmann V; Schnittger S; Schindela S; Klein HU; Eder C; Dugas M; Kern W; Haferlach T; Haferlach C; Kohlmann A
    J Mol Diagn; 2011 Mar; 13(2):129-36. PubMed ID: 21354046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of Technical, Bioinformatic, and Variant Assessment Approaches in the Validation of a Targeted Next-Generation Sequencing Panel for Myeloid Malignancies.
    Thomas M; Sukhai MA; Zhang T; Dolatshahi R; Harbi D; Garg S; Misyura M; Pugh T; Stockley TL; Kamel-Reid S
    Arch Pathol Lab Med; 2017 Jun; 141(6):759-775. PubMed ID: 28557600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-generation sequencing of custom amplicons to improve coverage of HaloPlex multigene panels.
    Coonrod EM; Durtschi JD; VanSant Webb C; Voelkerding KV; Kumánovics A
    Biotechniques; 2014 Oct; 57(4):204-7. PubMed ID: 25312090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplification of overlapping DNA amplicons in a single-tube multiplex PCR for targeted next-generation sequencing of BRCA1 and BRCA2.
    Schenk D; Song G; Ke Y; Wang Z
    PLoS One; 2017; 12(7):e0181062. PubMed ID: 28704513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A performance evaluation of Nextera XT and KAPA HyperPlus for rapid Illumina library preparation of long-range mitogenome amplicons.
    Ring JD; Sturk-Andreaggi K; Peck MA; Marshall C
    Forensic Sci Int Genet; 2017 Jul; 29():174-180. PubMed ID: 28448897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing copy number alterations in targeted, amplicon-based next-generation sequencing data.
    Grasso C; Butler T; Rhodes K; Quist M; Neff TL; Moore S; Tomlins SA; Reinig E; Beadling C; Andersen M; Corless CL
    J Mol Diagn; 2015 Jan; 17(1):53-63. PubMed ID: 25468433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inter-Laboratory Evaluation of a Next-Generation Sequencing Panel for Acute Myeloid Leukemia.
    Haslam K; Catherwood MA; Dobbin E; Sproul A; Langabeer SE; Mills KI
    Mol Diagn Ther; 2016 Oct; 20(5):457-61. PubMed ID: 27342108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimized Illumina PCR-free library preparation for bacterial whole genome sequencing and analysis of factors influencing de novo assembly.
    Huptas C; Scherer S; Wenning M
    BMC Res Notes; 2016 May; 9():269. PubMed ID: 27176120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted Next-Generation Sequencing of Acute Leukemia.
    Konnick E; Lockwood CM; Wu D
    Methods Mol Biol; 2017; 1633():163-184. PubMed ID: 28735487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of FLT3 internal tandem duplication in targeted, short-read-length, next-generation sequencing data.
    Spencer DH; Abel HJ; Lockwood CM; Payton JE; Szankasi P; Kelley TW; Kulkarni S; Pfeifer JD; Duncavage EJ
    J Mol Diagn; 2013 Jan; 15(1):81-93. PubMed ID: 23159595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the clinical utility of four NGS panels in myeloid malignancies. Suggestions for NGS panel choice or design.
    Aguilera-Diaz A; Vazquez I; Ariceta B; Mañú A; Blasco-Iturri Z; Palomino-Echeverría S; Larrayoz MJ; García-Sanz R; Prieto-Conde MI; Del Carmen Chillón M; Alfonso-Pierola A; Prosper F; Fernandez-Mercado M; Calasanz MJ
    PLoS One; 2020; 15(1):e0227986. PubMed ID: 31978184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted next-generation sequencing using a multigene panel in myeloid neoplasms: Implementation in clinical diagnostics.
    Maes B; Willemse J; Broekmans A; Smets R; Cruys B; Put N; Madoe V; Janssen M; Soepenberg O; Bries G; Vrelust I; Achten R; Van Pelt K; Buvé K; Theunissen K; Peeters V; Froyen G
    Int J Lab Hematol; 2017 Dec; 39(6):604-612. PubMed ID: 28722833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of two highly-multiplexed custom panels for massively parallel semiconductor sequencing on paraffin DNA.
    Kotoula V; Lyberopoulou A; Papadopoulou K; Charalambous E; Alexopoulou Z; Gakou C; Lakis S; Tsolaki E; Lilakos K; Fountzilas G
    PLoS One; 2015; 10(6):e0128818. PubMed ID: 26039550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinical grade sequencing-based assay for CEBPA mutation testing: report of a large series of myeloid neoplasms.
    Behdad A; Weigelin HC; Elenitoba-Johnson KS; Betz BL
    J Mol Diagn; 2015 Jan; 17(1):76-84. PubMed ID: 25468431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parallel tagged amplicon sequencing of relatively long PCR products using the Illumina HiSeq platform and transcriptome assembly.
    Feng YJ; Liu QF; Chen MY; Liang D; Zhang P
    Mol Ecol Resour; 2016 Jan; 16(1):91-102. PubMed ID: 25959587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Utility of a Next-Generation Sequencing Panel for Acute Myeloid Leukemia Diagnostics.
    Alonso CM; Llop M; Sargas C; Pedrola L; Panadero J; Hervás D; Cervera J; Such E; Ibáñez M; Ayala R; Martínez-López J; Onecha E; de Juan I; Palanca S; Martínez-Cuadrón D; Rodríguez-Veiga R; Boluda B; Montesinos P; Sanz G; Sanz MA; Barragán E
    J Mol Diagn; 2019 Mar; 21(2):228-240. PubMed ID: 30576870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of mutations in myeloid malignancies through paired-sample analysis of microdroplet-PCR deep sequencing data.
    Cheng DT; Cheng J; Mitchell TN; Syed A; Zehir A; Mensah NYT; Oultache A; Nafa K; Levine RL; Arcila ME; Berger MF; Hedvat CV
    J Mol Diagn; 2014 Sep; 16(5):504-518. PubMed ID: 25017477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.